Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jul-Sep;5(3):e23.
doi: 10.2196/jmir.5.3.e23. Epub 2003 Sep 29.

A Web-based screening instrument for depression and anxiety disorders in primary care

Affiliations

A Web-based screening instrument for depression and anxiety disorders in primary care

Peter Farvolden et al. J Med Internet Res. 2003 Jul-Sep.

Abstract

Background: Major depressive disorder (MDD) and anxiety disorders are common and result in considerable suffering and economic loss. People suffering from major depressive disorder and/or anxiety disorders are commonly encountered in the primary care setting. Unfortunately, most people with these disorders remain either untreated or inadequately treated; current data suggest that general practitioners fail to diagnose up to half of cases of major depressive disorder or anxiety. There is a need for screening tools that will help physicians and other professionals in primary care recognize and adequately treat major depressive disorder and anxiety disorders. While the currently-available self-report screening instruments have been demonstrated to be reliable and valid, there remain considerable barriers to their widespread use in primary care.

Objective: The purpose of the present study is to report preliminary validation data for a freely-available, brief, Web-based, self-report screener for major depressive disorder and anxiety disorders.

Methods: The Web-Based Depression and Anxiety Test (WB-DAT) was administered to 193 subjects who presented for assessment and/or treatment in ongoing research projects being conducted at the Mood and Anxiety Program and Clinical Research Department at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada. Subjects completed the Web-based screening instrument and were subsequently interviewed with the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) Axis I Disorders (SCID-I/P). The diagnostic data from the screening instrument were then compared with the data from the individual's SCID-I/P interview. Diagnostic concordance between SCID-I/P diagnoses and the Web-Based Depression and Anxiety Test were assessed using Cohen's kappa, sensitivity, specificity, positive predictive value, negative predictive value, and efficiency.

Results: Agreement ranged from acceptable to good (0.57-0.70) for major depressive disorder, panic disorder with and without agoraphobia (PD+/-AG), social phobia/social anxiety disorder, obsessive compulsive disorder (OCD), generalized anxiety disorder (GAD), and post traumatic stress disorder (PTSD). With the exception of generalized anxiety disorder, the sensitivity (0.71-0.95) and specificity (0.87-0.97) for the major diagnostic categories assessed by the Web-Based Depression and Anxiety Test were good. The sensitivity for generalized anxiety disorder was somewhat lower (0.63) but acceptable. Positive predictive values were good (0.60-0.75) for major depressive disorder, obsessive compulsive disorder, generalized anxiety disorder, and post traumatic stress disorder, and acceptable for panic disorder with and without agoraphobia and for social phobia/social anxiety disorder.

Conclusions: These preliminary data suggest that the Web-Based Depression and Anxiety Test is reliable for identifying patients with and without major depressive disorder and the anxiety disorders of panic disorder with and without agoraphobia, social phobia/social anxiety disorder, obsessive compulsive disorder, and post traumatic stress disorder. Further research is required in a larger sample in primary care.

PubMed Disclaimer

Conflict of interest statement

Dr. Farvolden has a potential conflict of interest in the publication of this paper in that he has acted as a paid consultant to Van Mierlo Communications Consulting Inc, the owner of Web-Based Depression and Anxiety Test content and software.

References

    1. Kennedy S H, Lam R W, Cohen N L, Ravindran A V CANMAT Depression Work Group, authors. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry. 2001 Jun;46 Suppl 1:38S–58S. - PubMed
    1. Parikh S V, Wasylenki D, Goering P, Wong J. Mood disorders: rural/urban differences in prevalence, health care utilization, and disability in Ontario. J Affect Disord. 1996 Apr 26;38(1):57–65. doi: 10.1016/0165-0327(95)00096-8.0165032795000968 - DOI - PubMed
    1. Kessler R C, Mcgonagle K A, Zhao S, Nelson C B, Hughes M, Eshleman S, Wittchen H U, Kendler K S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan;51(1):8–19. - PubMed
    1. Solomon D A, Keller M B, Leon A C, Mueller T I, Lavori P W, Shea M T, Coryell W, Warshaw M, Turvey C, Maser J D, Endicott J. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000 Feb;157(2):229–33. doi: 10.1176/appi.ajp.157.2.229. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=10671391. - DOI - PubMed
    1. Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May 24;349(9064):1498–504. doi: 10.1016/S0140-6736(96)07492-2.S0140673696074922 - DOI - PubMed

Publication types